SCHEMBL21731002

SCHEMBL21731002

c1cncc(-c2cc(-c3cccnc3)cc(-c3cccc(-c4c5ccc6ccccc6c5nc5c4ccc4ccc(-c6ccc7cc(-c8cc(-c9cccc(-c%10c%11ccc%12ccccc%12c%11nc%11c%10ccc%10ccccc%10%11)c9)cc(-c9ccc%10ccccc%10c9)c8)ccc7c6)cc45)c3)c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 10/20 0.59
CYP11B1 P15538 10/20 0.59
CYP19A1 P11511 7/20 0.59
CYP17A1 P05093 4/20 0.59
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HSD17B1 P14061 1/20 0.44
CYP2B6 P20813 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B2 P37059 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
KDM4E B2RXH2 3/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20081042 0.93 CYP11B1 (0.53) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL20089435 0.91 CYP11B1 (0.54) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL26467391 0.87 CYP11B2 (0.69) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL10030055 0.87 CYP11B2 (0.69) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL20080991 0.87 HSD17B1 (0.45) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL9887608 0.86 CYP11B2 (0.76) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL15004498 0.86 HSD17B1 (0.46) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL10300977 0.85 CYP11B2 (0.73) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL15977665 0.83 CYP11B2 (0.71) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL23784950 0.83 CYP11B2 (0.66) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145826-B2 Compound for electronic device and electronic device and display device NOVALED GMBH (DE) 2021-10-12 US disclosed
US-20200058880-A1 Compound for Electronic Device and Electronic Device and Display Device NOVALED GMBH (DE) 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200058880-A1 Compound for Electronic Device and Electronic Device and Display Device DRD2, DRD1, DRD3 CYP11B2 2537/4885CYP11B1 2949/4885CYP19A1 633/4885
US-11145826-B2 Compound for electronic device and electronic device and display device DRD2, DRD1, DRD3 CYP11B2 2537/4885CYP11B1 2949/4885CYP19A1 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.